)--Abiomed, Inc. (NASDAQ: ABMD) today announced an update on its European strategy to drive growth by establishing recovery as the goal for patients experiencing acute cardiac events.
)--Abiomed, Inc. (NASDAQ: ABMD) today announced an update on its European strategy to drive growth by establishing recovery as the goal for patients experiencing acute cardiac events.
